Newstral
Article
bizjournals.com on 2018-05-15 20:43
Aerie submits second drug for FDA approval
Related news
- Biogen Submits Promising Alzheimer’s Drug Aducanumab to FDA for Approvalobserver.com
- Cambridge's Agios wins FDA approval for second cancer drugbizjournals.com
- BAfter Lengthy Delay, Biogen Submits Troubled Alzheimer’s Drug for FDA Approvalbarrons.com
- Eyeing FDA approval, expanding Aerie also looking to Europebizjournals.com
- MAerie Pharma eye drug Rhopressa approved by FDAmarketwatch.com
- Vertex drug gets FDA approvalBoston Herald
- Mylan submits new drug application to FDAbizjournals.com
- Aratana lands second FDA approvalbizjournals.com
- MFDA grants a second approval to Ultragenyx drug for rare diseasemarketwatch.com
- Biogen, Eisai to push for fast FDA approval for second Alzheimer's drugbizjournals.com
- Philip Morris submits a tobacco vaporizer for FDA approvalengadget
- Johnson & Johnson Submits Booster Shot Data To FDA For ApprovalForbes
- Aratana sends fourth drug for FDA approvalbizjournals.com
- First CBD Drug Receives FDA Approvaljdsupra.com
- APrescient gets FDA approval for AML drugadelaidenow.com.au
- MCelgene's rare disease drug gets FDA approvalmarketwatch.com
- Full FDA drug approval: what it meansnwaonline.com
- FDA cuts back on fast drug approvalArkansas Online
- Diabetes drug gets FDA sale approvalnwaonline.com